20 März 2021
Data Sharing and the Public Interest in a Digital Pandemic*
COVID-19 is our first digital pandemic. An effective response to COVID-19 is reliant on access to data that can be used to identify COVID-19 hotspots, guide national and localised responses, as well as be used in research aimed at developing COVID-19 diagnostics, therapies and vaccines. This digital pandemic has thus seen a shift in our data practices. “Open science” and the rapid data sharing of the results of clinical trials, observational studies, operational research, routine surveillance, information on the virus and its genetic sequences, as well as the monitoring of disease control programmes has been pushed to a new level. Continue reading >>
0 